LCOV
OGN icon

London Company of Virginia’s Organon & Co OGN Stock Holding History

London Company of Virginia’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-299,242
Closed -$9.05M – 163
2021
Q2 		$9.05M Buy
+299,242
New +$9.85M 0.05% 106

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

London Company of Virginia's OGN Position: Q3 2021 in Review

London Company of Virginia sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 299,242 shares — an estimated $9.05M sold.

London Company of Virginia first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $9.05M in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

  • London Company of Virginia reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
  • London Company of Virginia sold 299,242 Organon & Co shares in Q3 2021, an estimated $9.05M.
  • London Company of Virginia first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
  • London Company of Virginia's Organon & Co position peaked at $9.05M in Q2 2021.
  • 928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on London Company of Virginia's 13F filing for Q3 2021, filed 15 Nov 2021.